comparemela.com

Despite the global challenges of high interest rates and geopolitical uncertainties, the economy remains resilient, buoyed by rising domestic demand and sectoral recovery. The outlook for H2 FY2023 and FY2024 looks positive, suggesting a resurgence in deals as market valuations stabilise. The financial health of the Indian companies is underscored by data from S&P Global Ratings, which projects a remarkable 50% increase in EBITDA by FY2024, while debt levels remain stable. This reflects a positive outlook for the corporate sector, demonstrating the strength of India's economy in the face of global adversity.

Related Keywords

United Kingdom ,Manipal ,Karnataka ,India ,Canada ,Hindustan ,India General ,Singapore ,Britain ,Thornton Bharat ,Biocon Biologics ,Adani Group ,India Inc ,Temasek ,Air India ,Tata Group ,Ambuja Cement ,Glaxosmithkline Consumer Healthcare ,Hindustan Unilever ,Uber Eats ,Tata Sons ,Grant Thornton Bharat ,Manipal Hospitals ,Serum Life Science ,West Asia ,Serum Life Sciences ,Moelis India ,Hdfc Bank ,Acc ,Nirma ,Zomato ,

© 2025 Vimarsana

comparemela.com © 2020. All Rights Reserved.